<DOC>
	<DOC>NCT00282685</DOC>
	<brief_summary>Treatment of patients with diabetic neuropathy by intraarterial progenitor cell transplantation.</brief_summary>
	<brief_title>Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy</brief_title>
	<detailed_description>Goal is: Stimulation of angiogenesis and induction of vasa nervorum in order to improve nerve function</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Patients with distal symmetrical diabetic neuropathy of the legs Type 1 or Type 2 Diabetes Stable Glucose control over last 3 months (Hba1c &lt;7.5) Written informed consent Patients with peripheral arterial disease (ABI &lt;0.9) Neuropathy of other origin Myopathy Asymmetrical neuropathy Active infection oder fever Chronic inflammatory disease (z.B M. Crohn, Rheumatoid Arthritis) HIV or hepatitis Neoplastic disease without complete remission within last 5 y Stroke or myocardial infarction within last 3 months Renal failure (creatinine &gt; 2 mg/dl) Liver disease (GOT &gt; 2 upper limit or spontaneous INR &gt; 1,5). Anemia (hemoglobine &lt; 8.5 mg/dl) Platelets &lt;100.000/Âµl HbA1c &gt;7,5 % Allergies to Aspirin, Clopidogrel, Heparin Bleeding disorder Surgery or trauma within the last 2 months Pregnancy Mental retardation Participation in another study within 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Patients with symmetric peripheral diabetic neuropathy</keyword>
</DOC>